Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol for Depression and Cardiovascular Health in Perimenopause
NCT01308814Phase 3Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Oct 2010
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of estradiol in major depressive disorder (MDD) and cardiovascular disease (CVD), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Center for Epidemiologic Studies Depression Scale at 12 months and Structured Clinical Interview for DSM Disorders at 12 months. Started Oct 2010; status: completed.
02
Drugs
estradiol
03
Conditions
major depressive disorder (MDD)cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01308814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01308814.